Sopharma AD
SPH.WAR
Exchange: | WAR |
Currency | Polish złoty |
ISIN: | BG11SOSOBT18 |
Fiscal Year End: | December |
Sector: | Healthcare |
Industry: | Medical Distribution |
Gic Sector: | Health Care |
Gic Group: | Health Care Equipment & Services |
Gic Industry: | Health Care Providers & Services |
Gic Sub Industry: | Health Care Distributors |
Description: | Sopharma AD produces, distributes, and exports pharmaceutical products in Europe, Bulgaria, and internationally. The company operates through Production of Pharmaceutical Products; Distribution of Pharmaceutical Products (Goods); and Others. It offers Carsil to treat liver disease; Tempalgin and Analgin, a painkiller; Tabex, drug used for smoking secession; Tribestan, drug used for stimulation of the male reproductive system; Broncholytin, which is used to suppress cough; Nivalin, used for diseases of the peripheral nervous system; Methylprednisolon, for severe allergies and life-threatening conditions; Vitamin C; Valeriana, used to reduce the stress; and medical devices, such as gauzes, compresses, and dressing. The company also provides food supplements; medicinal cosmetics, including plasters, bandages, and sanitary-hygiene products focused; and prescription medicines, on the counter products, and veterinary products. In addition, the company distributes pharmaceuticals, medical supplies, sanitary materials, vitamins, food supplements, and cosmetics; and provides contract manufacturing services; packaging services; and product development services. Further, it is involved in trading of food supplements; secondary packaging services for pharmaceutical products and real estate leases; trades, transports, and packages radioactive materials and nuclear equipment for medicinal use, household electronics, and electrical equipment; purchases, grows, produces, and trades in herbs and medicinal plant; and provision of public opinion research services. Additionally, the company engages in the offline and online retail trade of medicinal products and medical equipment; production of non-medicinal, and other products; and franchising, know-how, and rental of properties, as well as in trading, consulting, and other activities. Sopharma AD was founded in 1933 and is headquartered in Sofia, Bulgaria. |
Address: | 16 Iliensko shosse street, Sofia, Bulgaria, 1220 |
Website: | https://www.sopharmagroup.com |
Full Time Employees: | 4896 |
Updated On: | 2024-11-04 |
Highlights
Market Capitalization: | 2192387584 |
Market Capitalization Mln: | 2192.38 |
EBITDA: | 103624000 |
PE Ratio: | 12.11 |
Wall Street Target Price: | 4.2 |
Book Value: | 4.84 |
Dividend Share: | 0.09 |
Dividend Yield: | 0.02 |
Earnings Share: | 1.04 |
Most Recent Quarter: | 2024-06-30 |
Profit Margin: | 0.03 |
Operating Margin TTM: | 0.03 |
Return On Assets TTM: | 0.03 |
Return On Equity TTM: | 0.10 |
Revenue TTM: | 1974025984 |
Revenue Per Share TTM: | 13.03 |
Quarterly Revenue Growth YOY: | 0.09 |
Gross Profit TTM: | 364847000 |
Diluted Eps TTM: | 1.04 |
Quarterly Earnings Growth YOY: | -0.67 |
Valuation
Trailing PE: | 12.11 |
Forward PE: | 10.21 |
Price Sales TTM: | 1.11 |
Price Book MRQ: | 1.15 |
Enterprise Value: | 2943803332 |
Enterprise Value Revenue: | 0.67 |
Enterprise Value Ebitda: | 8.25 |
Shares
Shares Outstanding: | 165736000 |
Shares Float: | 40651682 |
Percent Insiders: | 65.05 |
Percent Institutions: | 0.17 |
Technicals
Beta: | -0.05 |
52 Week High: | 15.87 |
52 Week Low: | 11.4 |
50 Day MA: | 13.22 |
200 Day MA: | 13.40 |
Splits & Dividends
Forward Annual Dividend Rate: | 0.36 |
Forward Annual Dividend Yield: | 0.02 |
Payout Ratio: | 0.02 |
Ex Dividend Date: | 2024-11-07 |
Earnings
Report Date: | 2025-06-30 |
Date: | 2025-03-31 |
Before After Market: | After Market |
Currency: | BGN |
Report Date: | 2024-10-30 |
Date: | 2024-09-30 |
Before After Market: | After Market |
Currency: | BGN |
Report Date: | 2024-07-30 |
Date: | 2024-06-30 |
Before After Market: | After Market |
Currency: | BGN |
Eps Actual: | 0.21 |
Report Date: | 2024-04-30 |
Date: | 2024-03-31 |
Before After Market: | After Market |
Currency: | BGN |
Eps Actual: | 0.50 |
Report Date: | 2024-01-30 |
Date: | 2023-12-31 |
Before After Market: | After Market |
Currency: | BGN |
Eps Actual: | 0.18 |
Report Date: | 2023-09-30 |
Date: | 2023-09-30 |
Currency: | BGN |
Eps Actual: | 0.20 |
Report Date: | 2023-06-30 |
Date: | 2023-06-30 |
Currency: | BGN |
Eps Actual: | 0.58 |
Report Date: | 2023-03-31 |
Date: | 2023-03-31 |
Currency: | BGN |
Eps Actual: | 0.62 |
Report Date: | 2022-12-31 |
Date: | 2022-12-31 |
Currency: | BGN |
Eps Actual: | 0.05 |
Report Date: | 2022-09-30 |
Date: | 2022-09-30 |
Currency: | BGN |
Eps Actual: | 0.49 |
Report Date: | 2022-06-30 |
Date: | 2022-06-30 |
Currency: | BGN |
Eps Actual: | 0.44 |
Report Date: | 2022-03-31 |
Date: | 2022-03-31 |
Currency: | BGN |
Eps Actual: | 0.40 |
Report Date: | 2021-12-31 |
Date: | 2021-12-31 |
Currency: | BGN |
Eps Actual: | 0.75 |
Report Date: | 2021-09-30 |
Date: | 2021-09-30 |
Currency: | BGN |
Eps Actual: | 0.34 |
Report Date: | 2021-06-30 |
Date: | 2021-06-30 |
Currency: | BGN |
Eps Actual: | 0.25 |
Report Date: | 2021-03-31 |
Date: | 2021-03-31 |
Currency: | BGN |
Eps Actual: | 0.33 |
Report Date: | 2020-12-31 |
Date: | 2020-12-31 |
Currency: | BGN |
Eps Actual: | 0.14 |
Report Date: | 2020-09-30 |
Date: | 2020-09-30 |
Currency: | BGN |
Eps Actual: | 0.02 |
Report Date: | 2020-06-30 |
Date: | 2020-06-30 |
Currency: | BGN |
Eps Actual: | 0.17 |
Report Date: | 2020-03-31 |
Date: | 2020-03-31 |
Currency: | BGN |
Eps Actual: | 0.19 |
Report Date: | 2019-12-31 |
Date: | 2019-12-31 |
Currency: | BGN |
Eps Actual: | 0.92 |
Report Date: | 2019-09-30 |
Date: | 2019-09-30 |
Currency: | BGN |
Eps Actual: | 0.19 |
Report Date: | 2019-06-30 |
Date: | 2019-06-30 |
Currency: | BGN |
Eps Actual: | 0.12 |
Report Date: | 2019-03-31 |
Date: | 2019-03-31 |
Currency: | BGN |
Eps Actual: | 0.26 |
Report Date: | 2018-12-31 |
Date: | 2018-12-31 |
Currency: | BGN |
Eps Actual: | 0.02 |
Report Date: | 2018-09-30 |
Date: | 2018-09-30 |
Currency: | BGN |
Eps Actual: | 0.10 |
Report Date: | 2018-06-30 |
Date: | 2018-06-30 |
Currency: | BGN |
Eps Actual: | 0.14 |
Report Date: | 2018-03-31 |
Date: | 2018-03-31 |
Currency: | BGN |
Eps Actual: | 0.20 |
Report Date: | 2017-12-31 |
Date: | 2017-12-31 |
Currency: | BGN |
Eps Actual: | 0.12 |
Report Date: | 2017-09-30 |
Date: | 2017-09-30 |
Currency: | BGN |
Eps Actual: | 0.06 |
Report Date: | 2017-06-30 |
Date: | 2017-06-30 |
Currency: | BGN |
Eps Actual: | 0.19 |
Report Date: | 2017-03-31 |
Date: | 2017-03-31 |
Currency: | BGN |
Eps Actual: | 0.29 |
Report Date: | 2016-12-31 |
Date: | 2016-12-31 |
Currency: | BGN |
Eps Actual: | 0.33 |
Report Date: | 2016-09-30 |
Date: | 2016-09-30 |
Currency: | BGN |
Eps Actual: | 0.09 |
Report Date: | 2016-06-30 |
Date: | 2016-06-30 |
Currency: | BGN |
Eps Actual: | 0.27 |
Report Date: | 2016-03-31 |
Date: | 2016-03-31 |
Currency: | BGN |
Eps Actual: | 0.18 |
Report Date: | 2015-12-31 |
Date: | 2015-12-31 |
Currency: | BGN |
Eps Actual: | -0.04 |
Report Date: | 2015-09-30 |
Date: | 2015-09-30 |
Currency: | BGN |
Eps Actual: | -0.05 |
Report Date: | 2015-06-30 |
Date: | 2015-06-30 |
Currency: | BGN |
Eps Actual: | 0.28 |
Report Date: | 2015-03-31 |
Date: | 2015-03-31 |
Currency: | BGN |
Eps Actual: | 0.15 |
Report Date: | 2014-12-31 |
Date: | 2014-12-31 |
Currency: | BGN |
Report Date: | 2014-09-30 |
Date: | 2014-09-30 |
Currency: | BGN |
Eps Actual: | 0.03 |
Date: | 2024-09-30 |
Eps Actual: | 0.71 |
Date: | 2023-12-31 |
Eps Actual: | 1.59 |
Date: | 2022-12-31 |
Eps Actual: | 1.39 |
Date: | 2021-12-31 |
Eps Actual: | 1.69 |
Date: | 2020-12-31 |
Eps Actual: | 0.53 |
Date: | 2019-12-31 |
Eps Actual: | 1.51 |
Date: | 2018-12-31 |
Eps Actual: | 0.48 |
Date: | 2017-12-31 |
Eps Actual: | 0.68 |
Date: | 2016-12-31 |
Eps Actual: | 0.87 |
Date: | 2015-12-31 |
Eps Actual: | 0.34 |
Date: | 2014-12-31 |
Eps Actual: | 0.03 |